[Asia Economy Reporter Park Jihwan] Jeil Pharma Holdings announced on the 25th that it disposed of 117,900 shares (11.25%) of Korea Otsuka Pharmaceutical Co., Ltd. to its subsidiary Jeil Health Science through an in-kind contribution method.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
